Cellular platforms for HTS: Three case studies

Drug Discovery Today

Volumn 7, Issue 6, 2002, Pages 353-363

  Johnston, Paul A ^a   Johnston, Patricia A ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BETA GALACTOSIDASE; BETA LACTAMASE; CALCIUM ION; CELL NUCLEUS RECEPTOR; COMPLEMENTARY DNA; CYCLIC AMP; DIMETHYL SULFOXIDE; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HUMAN GROWTH HORMONE; IONOPHORE; LUCIFERASE; NEUROPEPTIDE RECEPTOR; RADIOLIGAND; TRANSCRIPTION FACTOR NFAT; TRANSFERASE; CARRIER PROTEIN; RADIOPHARMACEUTICAL AGENT;

BINDING ASSAY; CALCIUM TRANSPORT; CELL ASSAY; CELL CULTURE; CELL DENSITY; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CELL SCREENING; CELL SYNCHRONIZATION; CELL VIABILITY; COST BENEFIT ANALYSIS; DNA TRANSCRIPTION; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INDUCTION; FLUORESCENCE ANALYSIS; GENETIC TRANSCRIPTION; GENOMICS; HUMAN; INSTRUMENTATION; MEMBRANE PERMEABILITY; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VALIDATION PROCESS; ANIMAL; CHEMISTRY; CYTOLOGY; DRUG SCREENING; ECONOMICS; GENETICS; METABOLISM; PHARMACOLOGY; REPRODUCIBILITY;

ANIMAL; CARRIER PROTEINS; CELLS, CULTURED; CYTOLOGICAL TECHNIQUES; DRUG EVALUATION, PRECLINICAL; HUMAN; LUCIFERASE; PHARMACOLOGY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; ANIMALS; HUMANS; LUCIFERASES;

EID: 0037085583     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(01)02140-7     Document Type: Review

References (48)

1. Drug discovery: A historical perspective
2. High-throughput screening: New technology for the 21st century
3. High-throughput and ultra-high-throughput screening: Solution- and cell-based approaches
4. Technological advances in high-throughput screening
5. Cell-based versus isolated target screening: How lucky do you feel?
6. Cellular assays in HTS
7. Homogeneous pharmacologic and cell-based screens provide diverse strategies in drug discovery: Somatostatin antagonists as a case study
8. HTS approaches to voltage-gated ion channel drug discovery
9. Drug screening - Beyond the bottleneck
10. Screen idols: Faster, smaller, cheaper and smarter
11. Intracellular detection assays for high-throughput screening
12. Cell-based assays and instrumentation for screening ion-channel targets
13. Real-time molecular and cellular analysis: The new frontier in drug discovery
14. Quantification of G-protein coupled receptor internalization using G-protein coupled receptor-green fluorescent protein conjugates with the Arrayscan™ high-content screening system
15. Cytotoxicity tests for high-throughput drug discovery
16. High-throughput approaches for evaluating absorption, distribution, metabolism and excretion properties of lead compounds
17. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
18. Design of signal windows in high-throughput screening assays for drug discovery
19. A simple statistical parameter for use in evaluation and validation of high-throughput screening assays
20. Development of a high volume screen to identify inhibitors of endothelial cell activation
21. Desensitization of CGRP and adrenomedullin receptors in SK-N-MC cells: Implications for the RAMP hypothesis
22. Novel insulinoma cell line produced by iterative engineering of glut2, glukokinase, and human insulin expression
23. Molecular biology of serotonin receptors
24. Receptor subtype and density determine the coupling repertoire of the 5-HT2 receptor subfamily
25. Challenges of high-throughput screening against cell surface receptors
26. Reporter assays in the high-throughput screening laboratory: A rapid and robust first look
27. Selection of an optimal reporter gene for cell-based high throughput screening assays
28. Miniaturization of a mammalian cell-based assay: Luciferase reporter gene readout in a 3 microliter 1536-well plate
29. Measurement of responses from Gi-, Gs-, or Gq-coupled receptors by a multiple response element/cAMP response element-directed reporter assay
30. A cellular reporter assay to monitor insulin receptor kinase activity based on STAT 5-dependent luciferase gene expression
31. Development of a dual glow-signal firefly and Renilla luciferase assay reagent for the analysis of G-protein coupled receptor signaling
32. Development of a functional reporter gene HTS assay for the identification of mGluR7 modulators
33. Development of a facile method for high-throughput screening with reporter gene assays
34. Development and use of a gene promoter-based screen to identify novel inhibitors of cyclooxygenase-2 transcription
35. A chimeric reporter gene allowing clone selection and high-throughput screening of reporter cell lines expressing G-protein-coupled receptors
36. Development of a homogeneous MAP kinase reporter gene screen for the identification of agonists and antagonists at the CXCR1 chemokine receptor
37. Evaluation of a CRE-directed luciferase reporter gene assay as an alternative to cAMP accumulation
38. 2+ response amplitude and duration
39. FLIPR: A new instrument for accurate, high throughput optical screening
40. Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR
41. 2C receptors in CHO-K1 cells
42. 1A-adrenoreceptors
43. Characterization using FLIPR of human vanilloid VR1 receptor pharmacology
44. I-coupled receptors
45. Noninvasive, real-time method for the examination of thymidine uptake events - Application of the method to V-79 cell synchrony studies
46. Counting Cytostar-T™ scintillating microplates on the Microbeta® Jet
47. Measurement of calcium flux through ionotropic glutamate receptors using Cytostar-T scintillating microplates
48. Cytostar-T scintillating microplate assay for measurement of sodium-dependent bile acid uptake in transfected HEK-293 cells